Giraffe Bio secures $6.4M to scale copper recovery innovation
Argentine biotech startup Giraffe Bio closed a $6.4 million seed round led by Orion Industrial Ventures, with participation from BHP Ventures, Twynam, AIR Capital, and Baruch Future Ventures. Founded in 2024 by Alejandro Buffo Sempé and Juan Pablo Fernández, the company develops biochemical reagents that help mining companies recover more copper from ore using AI and biotechnology.
The capital will fund production scaling, industrial trials, research expansion, and hiring. Giraffe Bio operates in Chile and became the first Latin American startup selected for Breakthrough Energy's Fellows program, a climate technology accelerator backed by Bill Gates' ecosystem.
The company's technical documentation describes reagents designed to integrate into existing flotation circuits without requiring new equipment or flowsheet redesigns. In lab-scale validation using real mine samples under representative flotation conditions, the reagents demonstrated copper recovery improvements of 3 to 5 percentage points compared to current operations. Performance varies by mineralogy and operating conditions.
Orion Industrial Ventures targets seed to Series B companies working on extraction and processing, recycling, industrial biotechnology, and energy efficiency. BHP Ventures, the investment arm of global mining company BHP, brings operational expertise in large-scale mineral processing and access to mine sites for pilot deployment.
Before you start hiring
Check location, salary, and hiring fit
If you are moving from research to action, start with the market basics so your hiring plan is clearer.
Why biotech expansion signals growing AI talent demand in Argentina and Chile
Giraffe Bio's hiring push coincides with the transition from laboratory validation to industrial-scale trials, a phase requiring distinct technical capabilities. The startup currently lists two open positions: Senior Analytical Chemist and Senior Scientist in Biochemistry & Biophysics, both based in Buenos Aires and requiring on-site, full-time work.
Moving from lab to industrial trials demands specialists in process engineering, quality control, regulatory compliance, and field operations. Mining reagent companies at scale also need commercial teams familiar with mining procurement cycles.
Founder Juan Pablo Fernández holds a doctorate in biochemistry with postdoctoral work at Yale and previously led the genomic editing division at Rosario-based biotech BioHeuris from 2018 to 2023. Co-founder Alejandro Buffo Sempé graduated from Columbia Business School. This combination reflects a broader pattern in the Argentine biotech talent market, where academic research infrastructure produces strong life sciences graduates, but commercialization talent remains scarce.
The company's dual footprint in Argentina and Chile creates specific workforce planning challenges. Chile hosts the world's largest copper mining operations, making proximity to customers essential for field trials and technical support. Argentina offers access to a larger pool of biotechnology and computational biology talent at lower cost. Companies scaling biotech and AI teams across LATAM often adopt this model, centralizing research and AI development in Buenos Aires or São Paulo while placing application engineers and customer-facing roles near industrial clients.
S&P Global projects global copper demand will reach 42 million tonnes by 2040, with a supply deficit of 10 million tonnes. Copper is critical for electric vehicles, renewable energy infrastructure, power grids, and data center construction. This structural demand creates sustained hiring pressure across the mining technology value chain.
Team growth milestones to track as Giraffe Bio enters industrial trials phase
Giraffe Bio's hiring trajectory will signal how quickly the company can move from controlled lab conditions to full-scale industrial deployment. Industrial trials in mining require teams capable of operating in remote locations, managing large volumes of chemical formulations, and coordinating with mine site personnel on 24-hour schedules.
The technology relies on designing biomolecules that selectively interact with target mineral surfaces, then formulating them into reagents engineered for flotation performance. This process combines computational design, wet lab synthesis, formulation chemistry, and metallurgical testing. Bottlenecks in any stage can delay commercialization.
Selection for Breakthrough Energy Fellows provides access to a global network of technical advisors and potential customers, but also increases pressure for rapid scale-up. Program participants typically face expectations to demonstrate commercial traction. Meeting those timelines requires building internal processes for knowledge transfer, quality systems, and cross-functional coordination.
The investor syndicate brings complementary resources. Orion Industrial Ventures offers connections across the mining technology ecosystem and experience scaling hardware-intensive businesses. BHP Ventures can facilitate pilot projects at operating mine sites, reducing sales cycles for initial deployments. AIR Capital and Baruch Future Ventures provide access to portfolio companies working on adjacent problems in materials processing and industrial decarbonization.
Biotech startups serving industrial customers face different talent requirements than those in therapeutics or agriculture. Mining reagent development requires understanding flotation chemistry, mineral surface science, and the operational constraints of 24/7 processing plants. Universities in Chile and Argentina produce metallurgical engineers, but professionals combining biotechnology expertise with mining experience remain rare. Companies that train across disciplines or recruit from industrial enzymes or specialty chemicals gain competitive advantage.
As Giraffe Bio moves toward industrial trials, its ability to attract and retain technical talent in both Argentina and Chile will directly influence commercialization timelines and capacity to serve multiple mining customers.